Treatment of hemophilia A and von Willebrand's disease patients with an intranasal dripping of DDAVP.
D000281:Administration, Intranasal; D001127:Arginine Vasopressin / Q000008:administration & dosage*; D001777:Blood Coagulation / Q000187:drug effects; D002648:Child; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage*; D005169:Factor VIII / Q000276:immunology; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D010314:Partial Thromboplastin Time; D014842:von Willebrand Diseases / Q000188:drug therapy*; D014841:von Willebrand Factor
D014841:von Willebrand Factor; D001127:Arginine Vasopressin; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin